Do women in rural and remote areas need different guidelines for management of low-grade abnormalities found on cervical screening?

Gerard V Wain, Ian G Hammond, Penelope I Blomfield, Marion A Saville and Margaret Davy
Med J Aust 2006; 185 (3): . || doi: 10.5694/j.1326-5377.2006.tb00523.x
Published online: 7 August 2006

In reply: In June 2005, the National Health and Medical Research Council (NHMRC) endorsed new guidelines for managing asymptomatic women with screen-detected abnormalities because they were safe for Australian women and were based on the best available Australian and international evidence.1 The NHMRC accepted that new information about the natural history of human papillomavirus (HPV) infection of the cervix and cervical neoplasia demanded a reassessment of our traditional approach to this disease.

  • Gerard V Wain1
  • Ian G Hammond2
  • Penelope I Blomfield3
  • Marion A Saville4
  • Margaret Davy5

  • 1 Gynaecological Oncology, Westmead Hospital, Sydney, NSW.
  • 2 Gynaecological Oncology, King Edward Memorial Hospital, Perth, WA.
  • 3 Gynaecological Oncology, Royal Hobart Hospital, Hobart, TAS.
  • 4 Victorian Cytology Service, Melbourne, VIC.
  • 5 Gynaecological Oncology, Royal Adelaide Hospital, Adelaide, SA.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.